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Effects of Pharmacist Intervention on Blood Pressure In Black Patients
versus White Patients
Angela Kim, PharmD; Benjamin Rosati, PharmD, BCACP; Dawn Fuke, PharmD, BCPS

Background
• Racial disparities in hypertension outcomes have been recognized with
Black patients having greater risks than their white counterparts1,2
• Providence Medical Group (PMG) has placed a focus on attaining
quality metric goals for blood pressure control in eligible Black patients
• PMG Oregon has Collaborative Practice Agreements (CPAs) based on
pharmacist management in the primary care setting, and patients can
be referred by primary care providers for hypertension management
• Numerous studies have demonstrated the impact of clinical
pharmacist management on hypertension control3
• This study focuses on the impact of pharmacist intervention on
hypertension goal attainment in Black patients versus White patients

Objectives
Primary objective: Proportion of Black patients with a diagnosis of
hypertension with blood pressure of <140/90 after clinical pharmacy
services versus proportion of White patients with a diagnosis of
hypertension with blood pressure of <140/90 after clinical pharmacy
services
Select secondary objectives:
• Effect of total number of completed visits on blood pressure and goal
blood pressure attainment upon completion of clinical pharmacy
services in Black patients compared to white patients
• Effect of total number of scheduled visits on blood pressure and goal
blood pressure attainment upon completion of clinical pharmacy
services in Black patients compared to white patients
• Effect of number of patients lost to follow up on blood pressure and
goal blood pressure attainment upon completion of clinical pharmacy
services in Black patients compared to white patients
• Effect of total number of antihypertensive classes prescribed during
duration of clinical pharmacy services on blood pressure and goal
blood pressure attainment upon completion of clinical pharmacy
services in Black patients compared to white patients
Inclusion criteria:
• Age ≥18 years
• Established care with primary care provider one of 13 clinics
• Patients who self-identify as “Black or African American” with
diagnosis of hypertension
• Patients who self-identify as “White or Caucasian” and “Not Hispanic
or Latino” with diagnosis of hypertension
• At least one intervention with clinical pharmacy services from January
2019 to December 2019
Exclusion criteria:
• History of kidney transplant
• Hospice/end of life care
• Pregnant individuals
• Those who are incarcerated

Preliminary Results (cont.)

Methods

Secondary Objectives (cont.)

•Study design: Retrospective observational repeated measure
•Patients enrolled in 3:1 fashion (3 White patients for every 1 Black patient)
•Statistical tests
Primary objective: Proportion test
Secondary objectives: Generalized linear model

Preliminary Results
Patient Demographics (n = 72)

Average age (yrs)
Female sex (%)
Insurance coverage
Commercial
Medicaid
Medicare
None

Black patients
(n = 18)
59 (36-77)
10 (55.5%)

White patients
(n = 54)
65 (38-87)
27 (50%)

11 (61.1%)
0
7 (38.9%)
0

20 (37%)
5 (9.3%)
26 (48.1%)
3 (5.6%)

Primary Objective (n = 72)

Blood Pressure at target <140/90 after CPS intervention
100%
80%
60%

50%

44.4%

Black patients
(n = 18)

White patients
(n = 54)

40%
20%
0%

Secondary Objectives
Black patients
(n = 18)

White patients
(n = 54)

Mean # of completed visits

5.8 (1-37)

4.7 (1-62)

Mean # of scheduled visits

9.9 (1-59)

5.7 (1-78)

# lost to follow up
# hospitalizations/ER
visits/urgent care visits for CV
events

4 (22.2%)

9 (16.7%)

4 (22.2%)

0

0

0

# clinic visits for hypertensive
urgency/emergency

Black patients

White patients

Mean change in SBP

-1.6 (30 – 34)

0.5 (59 – 61)

Mean change in DBP

3.4 (11 – 31)

-0.5 (30 – 38)

Mean change in # of
antihypertensives

0.21 (1-5)

0.18 (0-5)

Discussion
Conclusion: Pending statistical analysis. Estimated completion of
statistical analysis is 5/2022

Limitations
• Reports used to identify patients may have been incomplete due to
variances in charting for visit diagnoses and documentation by
pharmacists
• Reports did not capture patients managed by pharmacists from
excluded clinics
• Antihypertensive dose changes not captured
• Differences in practices between pharmacists to proactively
reschedule patients who cancel or no show
• Study did not account for differences in individualized blood pressure
goals
• Small study population
• The study extended into the COVID-19 pandemic and may have
affected in-person follow up visits and overall blood pressure
management
• Did not assess the rate of referral of Black vs White patients to clinical
pharmacy services for hypertension management
• Patient compliance to antihypertensive not taken into consideration

Future Considerations
• Consider evaluating blood pressure goal attainment in clinical
pharmacist managed versus primary care provider or specialist
managed patients
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